Menotrophin Ferring

Menotropin, the active ingredient in Menotrophin Ferring, is a gonadotropin presented as a sterile solution for intramuscular and subcutaneous use. It provides exogenous FSH and LH activity to stimulate ovarian follicular development in women and support spermatogenesis in men with certain infertility disorders.

GNH USA supplies Menotrophin Ferring as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Menotrophin is a gonadotropin used in reproductive medicine to stimulate follicular development and spermatogenesis. - Induction of ovulation in women with anovulation: promotes follicular growth to enable ovulation. - Ovarian stimulation for assisted reproductive technology (e.g., IVF): enhances multiple follicle development for egg retrieval. - Stimulation of spermatogenesis in men with hypogonadotropic hypogonadism: provides LH and FSH activity to support sperm production.

Menotrophin may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Injection site pain: mild discomfort or redness at the injection site. - Headache: transient headache of varying intensity. - Nausea: occasional feeling of nausea. - Abdominal discomfort: mild pelvic or abdominal pain. - Ovarian hyperstimulation symptoms: mild abdominal bloating or mild weight gain. - Gynecomastia in men: breast tenderness or enlargement.

Serious or Rare Side Effects: - Ovarian hyperstimulation syndrome (OHSS): severe abdominal pain, ascites, thromboembolism. - Multiple pregnancy: increased risk of twins or higher‑order gestations. - Allergic reaction: rash, urticaria, or anaphylaxis. - Thromboembolic events: deep vein thrombosis or pulmonary embolism.

Before using Menotrophin, consider the following precautions to ensure safe and effective treatment. - Pregnancy testing: confirm non‑pregnant status before initiating therapy. - Ovarian monitoring: perform regular ultrasound to assess follicular response. - Hormone levels: check baseline FSH, LH, estradiol, and testosterone as appropriate. - Thromboembolic risk: evaluate history of clotting disorders before treatment. - Allergies: avoid use if known hypersensitivity to Menotrophin or its excipients. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Menotrophin can interact with other medicines; awareness of major and moderate interactions helps manage risk.

Major Interactions (Avoid): - GnRH antagonists: may blunt the intended gonadotropin response. - High‑dose estrogen therapy: can suppress endogenous gonadotropin activity. - Anticoagulants: increased risk of bleeding with ovarian hyperstimulation.

Moderate Interactions (Monitor Closely): - Oral contraceptives: may require washout period before starting Menotrophin. - Thyroid hormones: altered metabolism may affect reproductive hormone balance. - Steroids (e.g., prednisone): may influence follicular development.